International Conference on Pharmaceutics and Drug Delivery Systems
International Conference on Pharmaceutics and Drug Delivery Systems is scheduled for 23-24 April 2020 in Dubai, United Arab Emirates. Theme:
Category: Drug delivery
Supreme delivery effect of β-cyclodextrin for hypoxic cancer cells recognized in 2019 Nobel prize laureate’s lab
2019 Nobel prize in Physiology or Medicine will be awarded to William G. Kaelin Jr., Sir Peter J. Ratcliffe and
European Symposium on Controlled Drug Delivery
The 16th edition of the European Symposium on Controlled Drug Delivery will be held on April 8 – 10, 2020
A new multi-compendia modified beta-cyclodextrin, Kleptose® HPB-LB parenteral grade
Increased interest in cyclodextrins (CDs) in recent years has led to a strong market demand, and several new pharmaceutical products
Cyclodextrins in doll-inspired nanostructures for cancer therapy
A young researcher working at the Centre de Recherche en Automatique de Nancy, Centre National de la Recherche Scientifique has recently
Ligand Partner CASI Pharmaceuticals Launches EVOMELA® in China
SAN DIEGO–(BUSINESS WIRE)– Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) partner CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a U.S. biopharmaceutical company focused on
Encapsulation of sulfamethazine by native and randomly methylated β-cyclodextrins
Sulfonamides are preventive and therapeutic agents for certain infections caused by gram-positive and gram-negative microorganisms. In this work the interactions
New real-world data support long-term efficacy and safety profile of MAVENCLAD
Merck, a leading science and technology company, announced the presentation of new data for MAVENCLAD® (cladribine tablets), which further characterise
Pharma-Congress – 2019
The conference on “Pharmaceutical Drug Research and Industry Field Innovations” is scheduled to be held on November 25-26, 2019 Singapore. The theme
Engineered cyclodextrin derivatives for spontaneous coating of highly porous metal-organic framework nanoparticles
Nanosized metal-organic frameworks (nanoMOFs) MIL-100(Fe) are highly porous and biodegradable materials that have emerged as promising drug nanocarriers. A challenging